|
1
|
Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute Randomized Trial.
|
Cancer
|
2003
|
2.77
|
|
2
|
Amphetamine, past and present--a pharmacological and clinical perspective.
|
J Psychopharmacol
|
2013
|
1.22
|
|
3
|
Twenty-five year results of the national cancer institute randomized breast conservation trial.
|
Breast Cancer Res Treat
|
2011
|
1.01
|
|
4
|
Regulatory challenges for new drugs to treat obesity and comorbid metabolic disorders.
|
Br J Clin Pharmacol
|
2009
|
0.99
|
|
5
|
What is the prognosis for new centrally-acting anti-obesity drugs?
|
Neuropharmacology
|
2012
|
0.88
|
|
6
|
Early ipsilateral breast tumor recurrences after breast conservation affect survival: an analysis of the National Cancer Institute randomized trial.
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.86
|
|
7
|
A phase I trial of a potent P-glycoprotein inhibitor, Zosuquidar.3HCl trihydrochloride (LY335979), administered orally in combination with doxorubicin in patients with advanced malignancies.
|
Clin Cancer Res
|
2002
|
0.85
|
|
8
|
Cochlear implantation in the elderly: results and quality-of-life assessment.
|
Ann Otol Rhinol Laryngol
|
2002
|
0.83
|
|
9
|
Metabolic consequences of antipsychotic therapy: preclinical and clinical perspectives on diabetes, diabetic ketoacidosis, and obesity.
|
Handb Exp Pharmacol
|
2012
|
0.82
|
|
10
|
ADHD: current and future therapeutics.
|
Curr Top Behav Neurosci
|
2012
|
0.80
|
|
11
|
Implications of climate change for northern Canada: the physical environment.
|
Ambio
|
2009
|
0.78
|
|
12
|
Implications of climate change for economic development in northern Canada: energy, resource, and transportation sectors.
|
Ambio
|
2009
|
0.75
|
|
13
|
The National Trauma Institute: Lessons learned in the funding and conduct of 16 trauma research studies.
|
J Trauma Acute Care Surg
|
2016
|
0.75
|